genetic peptides retatrutide – 6mg – Prime Lab Retatrutide 10 mg | World
Description
Early treatment phases often require close attention, while stable patients may benefit from extended intervals and digital support
[1] [2] You should also schedule a routine review if gastrointestinal side effects persist beyond 46 weeks without improvement, as this may indicate the need for dose adjustment, additional symptomatic management, or consideration of alternative weight management strategies
Individuals with a personal or family history of thyroid tumours should be aware that, in common with other GLP-1 receptor agonists, retatrutide's GLP-1 activity may carry a theoretical thyroid risk
Once weekly
